Pfizer will buy cancer drugmaker Array BioPharma for $10.6 billion
Pfizer will buy Array BioPharma for $10.6 billion to gain its promising new medicines for cancer, which could end or limit the use of punishing chemotherapy for some patients.
More from Nebraska Lifestyle
Edge Magazine
A Life, Well Designed: The B. Morton Design Philosophy
Nebraska Lifestyle
•
Sep 29, 2026
Edge Magazine
Elevated Living, Inside and Out: Thoughtfully Transformed - Sophisticated and Welcoming
Nebraska Lifestyle
•
Sep 29, 2026
